Bridge Advisory’s Pfizer PFE Stock Holding History

Bridge Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,116	Closed	-$263K	–	99
2021 Q3	$263K	Hold	6,116	–	–	0.13%	74
2021 Q2	$240K	Sell	6,116 -491	-7%	-$19.1K	0.12%	75
2021 Q1	$239K	Buy	6,607 +185	+3%	+$6.57K	0.15%	61
2020 Q4	$236K	Buy	+6,422	New	+$236K	0.11%	72

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bridge Advisory's PFE Position: Q4 2021 in Review

Bridge Advisory sold out of Pfizer (PFE) in Q4 2021, closing a stake of 6,116 shares — an estimated $263K sold.

Bridge Advisory first reported a position in PFE in Q4 2020 and held it in 4 quarters. The position peaked at $263K in Q3 2021. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Bridge Advisory reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
Bridge Advisory sold 6,116 Pfizer shares in Q4 2021, an estimated $263K.
Bridge Advisory first reported a position in Pfizer in Q4 2020 and held it in 4 quarters.
Bridge Advisory's Pfizer position peaked at $263K in Q3 2021.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Bridge Advisory's 13F filing for Q4 2021, filed 19 Jan 2022.